Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune responses of NDV-HXP-S vaccine with heterologous booster after 12 months in adults
TCTR20230809003Phase 2Completed
- Sponsor
- National Research Council of Thailand
- Start
- Jun 2023
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Patria in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Started Jun 2023; status: completed.
02
Drugs
Patria
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20230809003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230809003.